You are here

Eli Lilly

Lilly cancer push boosted by survival benefit to key drug

Biopharma Dive

Tue, 07/30/19 - 11:31 am

metastatic breast cancer

clinical trials

Lilly drops PD-L1/TIM-3 bispecific from clinical pipeline

Fierce Biotech

Tue, 07/30/19 - 11:23 am

bispecific antibodies

After painting a poor safety profile, Pfizer and Eli Lilly are shooting for a new pain drug OK anyway

Endpoints

Mon, 07/29/19 - 09:30 am

The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate

Yahoo/Benzinga

Sun, 07/28/19 - 11:48 pm

Leap Therapeutics

Cidara Therapeutics

Spark Therapeutics

clinical trials

In a first, Lilly's ready-to-use rescue hypoglycemia powder wins US approval

Endpoints

Thu, 07/25/19 - 10:40 am

These 5 Firms Could Buy Celgene's Otezla Ahead Of The Bristol Merger

Investors Business Daily

Fri, 07/19/19 - 10:44 am

Bristol-Myers Squibb

Gilead Sciences

Emgality-maker Lilly courts payers with new migraine ER data

Fierce Pharma

Fri, 07/12/19 - 12:22 pm

cluster headache

Teva Pharmaceutical

Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs

Xconomy

Thu, 07/11/19 - 11:15 pm

Alzheimer's disease

BACE inhibitors

Bayer floats animal health merger with Lilly spinoff Elanco: report

Fierce Pharma

Tue, 07/9/19 - 06:47 pm

Array, Pierre Fabre bowel cancer therapy ‘could replace chemo’

Pharmaforum

Mon, 07/8/19 - 09:48 am

Array Biopharma

colorectal cancer

clinical trials

Lilly's Study on Higher Doses of Trulicity Meets Endpoint

Yahoo/Zacks.com

Thu, 06/27/19 - 06:43 pm

clinical trials

type 2 diabetes

FDA fast-tracks BI, Lilly's Jardiance in chronic heart failure

Fierce Pharma

Wed, 06/26/19 - 04:59 pm

Boehringer Ingelheim

chronic heart failure

Lilly enlists patients to raise cluster headache awareness after Emgality scores second nod

Fierce Pharma

Wed, 06/26/19 - 04:56 pm

cluster headaches

Can A Drug That Delays The Onset Of Type 1 Diabetes Be A Success?

Forbes

Tue, 06/25/19 - 07:23 pm

type 1 diabetes

Amgen, Lilly, Merck sue HHS to block price disclosures in DTC ads

BioCentury

Fri, 06/14/19 - 06:26 pm

Lilly’s Taltz scrapes win against Humira in psoriatic arthritis

Pharmaforum

Fri, 06/14/19 - 06:22 pm

psoriatic arthritis

House progressives challenge drugmakers to come back to Capitol Hill

Stat

Wed, 06/12/19 - 06:52 pm

Gilead Sciences

Look here, FDA: Eli Lilly touts Olumiant safety data for unapproved high dose

Fierce Pharma

Wed, 06/12/19 - 06:43 pm

rheumatoid arthritis

Eli Lilly's Taltz touts long-term clear skin data after unimpressive first-quarter sales

Fierce Pharma

Tue, 06/11/19 - 06:00 pm

ADA: Lilly, Boehringer's DPP-4 drug Tradjenta ties generic rival in heart safety study

Fierce Pharma

Tue, 06/11/19 - 12:06 pm

Boehringer Ingelheim

Pages